Multiple-lesion, non-familial basal cell carcinoma-An interesting oddity

---

Case Report

Author Details : Kirti G Pardeshi, Hoogar Mallinath Basalingappa, Satish Bhasale, Sameer Arun Kadam*, Vaishali Bhonsle, Nakul Sampat, Arvind Valand

Volume : 8, Issue : 4, Year : 2023

Article Page : 225-229

https://doi.org/10.18231/j.jdpo.2023.053

Suggest article by email

Get Permission

---

Abstract

Basal cell carcinoma (BCC) is the most common primary carcinoma of skin, which accounts for three-fourth of all primary skin tumours. Basal carcinoma occurs commonly as a single lesion, though occasionally it can occur as Multiple lesions, which may occur in close association with heredofamilial conditions such as nevoid basal cell carcinoma syndrome (Gorlin’s syndrome), Bazex syndrome, Rombo syndrome, and unilateral basal cell nevus syndrome. The case of multiple basal cell carcinomas being presented here is unique in its occurrence inasmuch as it is not associated with heredofamilial conditions, and despite not being associated with heredofamilial conditions there is occurrence of multiple basal carcinomas in a patient in a tertiary care hospital in a dominantly tribal region. The patient has no family history of genodermatosis that could increase the incidence of multiple basal cell carcinomas such as xeroderma pigmentosum, and no history of other predisposing conditions including actinic keratosis, Bowen’s Disease, leukoplakia, Erythroplasia of Queyrat, keratoacanthoma, radiation dermatitis and exposure to arsenicals, psoralen and other photosensitizing medications. However, the patient had history of having raised macules over the face which were diagnosed as seborrheic keratosis.
 

Keywords: Basal cell carcinoma, multi­lesion BCC, non­syndromic BCC, non­familial BCC, multiple Basal cell carcinomas, Gorlin syndrome, nevoid basal cell carcinoma

How to cite : Pardeshi K G, Basalingappa H M, Bhasale S, Kadam S A, Bhonsle V, Sampat N, Valand A, Multiple-lesion, non-familial basal cell carcinoma-An interesting oddity. IP J Diagn Pathol Oncol 2023;8(4):225-229

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.